Zosyn Injection Shortage: New FDA Information
The initial shortage of Zosyn Injection, reported in April 2014, was due to a delay in shipping of the drug. Other generic manufacturers are currently reporting an intermittent backorder and/or a limited supply of certain dosage strengths.
Zosyn is a broad-spectrum penicillin + β-lactamase inhibitor indicated for the treatment of susceptible intra-abdominal infections (eg, appendicitis, peritonitis), skin and skin structure, moderate community-acquired pneumonia, moderate to severe nosocomial pneumonia, postpartum endometritis, and pelvic inflammatory disease.
For more information visit FDA.gov.